Microarrays in primary breast cancer - Lessons from chemotherapy studies

Endocrine-Related Cancer

Volumn 8, Issue 3, 2001, Pages 259-263

  Lonning P E ^a   Sorlie T ^a   Perou, C M ^a   Brown, P O ^a   Botstein, D ^a   Borresen Dale A L ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GENETICS; CANCER RESISTANCE; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; ONCOGENE; PREDICTION; PROGNOSIS; TECHNIQUE;

BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; FLUORESCENT DYES; GENE EXPRESSION PROFILING; GENES, ERBB-2; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0347912972     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0080259     Document Type: Conference Paper

References (21)

1. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
2. Polychemotherapy for early breast cancer: An overview of the randomised trials
3. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
4. Epidermal growth factor receptor in human breast cancer: Correlation with steroid hormone receptors and axillary lymph node involvement
5. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading
6. Tamoxifen for early breast cancer: An overview of the randomised trials
7. Exploring the metabolic and genetic control of gene expression on a genomic scale
8. DNA arrays for analysis of gene expression
9. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: Findings from national surgical adjuvant breast and bowel project protocol B-06
10. Pathologic findings from the national surgical adjuvant breast project protocol B-06
11. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer
12. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
13. The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease
14. TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients
15. erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
16. Molecular portraits of human breast tumours
17. Systematic variation in gene expression patterns in human cancer cell lines
18. The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO ('Novaldex') trial
19. Androgen receptors in operable breast cancer: Relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment
20. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
21. The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients